Showing results (81-90 of 366) with videos related to
Sort By:
Pageof 37
Future Medicinal Chemistry|November 29, 2019
Public resources for chemical probes: the journey so far and the road aheadAlbert A Antolin, Paul Workman, Bissan Al-LazikaniExpert Opinion on Emerging Drugs|May 25, 2004
Histone modification enzymes: novel targets for cancer drugsRebecca Kristeleit, Lindsay Stimson, Paul Workman, et al.Annals of the New York Academy of Sciences|May 22, 2007
Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stressPaul Workman, Francis Burrows, Len Neckers, et al.Drug Discovery Today|December 26, 2021
Enhancing access to innovative cancer drugs: Cross-sector consensus on a way forward to benefit patientsRichard Hoey, Eva Sharpe, Angela Kukula, et al.Cell Cycle (Georgetown, Tex.)|February 7, 2009
Death by chaperone: HSP90, HSP70 or both?Marissa V Powers, Paul A Clarke, Paul WorkmanCancer Cell|September 6, 2008
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosisMarissa V Powers, Paul A Clarke, Paul WorkmanMolecular Cancer Therapeutics|February 20, 2007
The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discoveryNicola F Smith, Florence I Raynaud, Paul WorkmanCancer Cell|April 21, 2012
Personalized medicine: patient-predictive panel powerPaul Workman, Paul A Clarke, Bissan Al-LazikaniEuropean Journal of Cancer (Oxford, England : 1990)|November 16, 2004
Gene expression microarray technologies in the development of new therapeutic agentsPaul A Clarke, Robert te Poele, Paul WorkmanPageof 37